Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

giiant pharma inc. is a Montreal-based biotech company, founded by former Merck Frosst scientists, with the aim of developing orally-administered, gut-restricted anti-inflammatory agent for the treatment of IBD. Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in...
giiant pharma inc. is a Montreal-based biotech company, founded by former Merck Frosst scientists, with the aim of developing orally-administered, gut-restricted anti-inflammatory agent for the treatment of IBD. Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.

List your booth number for exhibitions, ask us